Results 271 to 280 of about 3,567,945 (293)
Some of the next articles are maybe not open access.

An Extended Lymphocytotoxicity Test for Patients Treated with Lymphocytotoxic Antibodies

Vox Sanguinis, 2000
AbstractBackground and Objectives:After organ transplantation, HLA antibodies (HLA‐Ab) stimulated by transplant or transfusion are usually indistinguishable from passive therapeutic lymphocytotoxic antibodies (LyAb), e.g. antilymphocyte globulin (ALG), antithymocyte globulin (ATG) and OKT3, by standard lymphocytotoxicity tests (LCTs).
A. Salama, R. Kohlhaus, A. Moldenhauer
openaire   +3 more sources

TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION

Retina, 2016
To evaluate the effects of aflibercept therapy using a treat-and-extend regimen on treatment-naïve retinal angiomatous proliferation (RAP) and development of retinal pigment epithelium (RPE) atrophy.We retrospectively studied 17 treated eyes with RAP and 13 untreated fellow eyes.
Shoji Kishi   +9 more
openaire   +3 more sources

Deep neck space infection extending to the mediastinum that was treated conservatively

BMJ Case Reports, 2022
Deep neck space infections (DNSIs) are challenging to diagnose and manage. A female ex-smoker presented with difficulty breathing and chest pain. She was initially treated for exacerbation of emphysema with intravenous antibiotics. The ear, nose and throat team were later asked to review the patient for left submandibular swelling and odynophagia.
Haran Devakumar   +3 more
openaire   +2 more sources

Changes of Plasma Fibronectin in Patients Treated with Cryofiltration for an Extended Period

Therapeutic Apheresis, 1999
Abstract: The purpose of this study was to evaluate correlations between extra domain A fibronectin (EDA[+]FN) in plasma and the clinical course in cryofiltration for an extended period. Two patients with systemic lupus erythematosus (SLE), 1 with aortitis syndrome, 1 with ankylosis spondylitis, 1 with polymyositis, 1 with rheumatoid arthritis, and 1 ...
Tohru Tamaki   +5 more
openaire   +3 more sources

Treat and extend versus PRN in diabetic retinopathy

Acta Ophthalmologica, 2016
SummaryVascular endothelial growth factor (VEGF) plays a key role in the pathogenesis of the neo‐vascular age related macular degeneration (nAMD) and the ischemic retinal microangiopathies. Targeting VEGF in retinal diseases became an effective therapeutic option.To optimize the benefit of risk ratio and cost effectiveness of anti‐VEGF agents, a number
openaire   +2 more sources

Extended Capability for Fast Neutron Hodoscope Used at Treat

IEEE Transactions on Nuclear Science, 1968
The fast neutron hodoscope used at TREAT reactor for fuel meltdown studies has been improved to permit count rates above 106/sec in each channel. Also a digital readout system, based on integrated circuit scalers, has been introduced. Peak instantaneous data rate capability, now about 107/sec, can be expanded to 109/sec.
R. Pecina   +5 more
openaire   +2 more sources

Efficacy of levomilnacipran extended release in treating major depressive disorder

Expert Opinion on Pharmacotherapy, 2017
Major depressive disorder (MDD) is the leading cause of disability worldwide with a heterogeneous symptom profile. Levomilnacipran extended release (ER) (Fetzima), a SNRI, has been approved by the Food and Drug Administration for treatment of MDD.
Roger S. McIntyre   +3 more
openaire   +3 more sources

Use of the Extended Trochanteric Osteotomy in Treating Prosthetic Hip Infection

The Journal of Arthroplasty, 2009
The goal of this study is to evaluate the efficacy of using an extended trochanteric osteotomy (ETO) as part of a 2-stage exchange procedure for prosthetic hip infections. Twenty-three consecutive infected total hip arthroplasties in which an ETO was used as part of a 2-stage exchange procedure were retrospectively reviewed.
Mark Hamming   +5 more
openaire   +3 more sources

Extended Follow-up of Patients Treated With Bendamustine for Lymphoid Malignancies

Clinical Lymphoma Myeloma and Leukemia, 2017
Bendamustine, typically in combination with rituximab, is an effective treatment for chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin lymphoma. Despite its acceptable short-term toxicity profile, long-term toxicities are less well established.
Maryam Sarraf Yazdy   +3 more
openaire   +3 more sources

Giant ancient schwannoma of pancreatic head treated by extended pancreatoduodenectomy

Pancreatology, 2004
We report a case of a 55-year-old woman who was transferred from another center to our university clinic after diagnostic laparotomy with a pancreatic head tumor which was seen to encase the portal vein. Although intraoperative biopsies were performed, a histologic diagnosis of the tumor was not possible before giving suspect to a malignant tumor being
Dobschütz, Ernst von   +4 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy